438 related articles for article (PubMed ID: 17265133)
1. The impact of legalizing syringe exchange programs on arrests among injection drug users in California.
Martinez AN; Bluthenthal RN; Lorvick J; Anderson R; Flynn N; Kral AH
J Urban Health; 2007 May; 84(3):423-35. PubMed ID: 17265133
[TBL] [Abstract][Full Text] [Related]
2. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
[TBL] [Abstract][Full Text] [Related]
3. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
[TBL] [Abstract][Full Text] [Related]
4. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.
Beletsky L; Grau LE; White E; Bowman S; Heimer R
Addiction; 2011 Feb; 106(2):357-65. PubMed ID: 21054615
[TBL] [Abstract][Full Text] [Related]
5. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.
Bluthenthal RN; Kral AH; Erringer EA; Edlin BR
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):505-11. PubMed ID: 9715848
[TBL] [Abstract][Full Text] [Related]
6. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco.
Bluthenthal RN; Kral AH; Lorvick J; Watters JK
Med Anthropol; 1997 Dec; 18(1):61-83. PubMed ID: 9458668
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions.
Beletsky L; Grau LE; White E; Bowman S; Heimer R
Drug Alcohol Depend; 2011 Dec; 119(1-2):145-9. PubMed ID: 21705159
[TBL] [Abstract][Full Text] [Related]
8. The legality of selling or giving syringes to injection drug users.
Burris S; Vernick JS; Ditzler A; Strathdee S
J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
[TBL] [Abstract][Full Text] [Related]
9. Secondary syringe exchange among users of 23 California syringe exchange programs.
Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
[TBL] [Abstract][Full Text] [Related]
10. State syringe and drug possession laws potentially influencing safe syringe disposal by injection drug users.
Burris S; Welsh J; Ng M; Li M; Ditzler A
J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S94-8. PubMed ID: 12489625
[TBL] [Abstract][Full Text] [Related]
11. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.
Bluthenthal RN; Anderson R; Flynn NM; Kral AH
Drug Alcohol Depend; 2007 Jul; 89(2-3):214-22. PubMed ID: 17280802
[TBL] [Abstract][Full Text] [Related]
12. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention.
Case P; Meehan T; Jones TS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S71-5. PubMed ID: 9663627
[TBL] [Abstract][Full Text] [Related]
13. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
[TBL] [Abstract][Full Text] [Related]
14. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland.
Gleghorn AA; Jones TS; Doherty MC; Celentano DD; Vlahov D
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):97-103. PubMed ID: 7648292
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.
Green TC; Bluthenthal RN; Singer M; Beletsky L; Grau LE; Marshall P; Heimer R
Drug Alcohol Depend; 2010 Sep; 111(1-2):74-81. PubMed ID: 20537814
[TBL] [Abstract][Full Text] [Related]
16. Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.
Cooper H; Des Jarlais D; Ross Z; Tempalski B; Bossak BH; Friedman SR
J Urban Health; 2012 Aug; 89(4):678-96. PubMed ID: 22585448
[TBL] [Abstract][Full Text] [Related]
17. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.
Groseclose SL; Weinstein B; Jones TS; Valleroy LA; Fehrs LJ; Kassler WJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):82-9. PubMed ID: 7648290
[TBL] [Abstract][Full Text] [Related]
18. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
19. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
[TBL] [Abstract][Full Text] [Related]
20. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies.
Kral AH; Anderson R; Flynn NM; Bluthenthal RN
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1307-12. PubMed ID: 15385739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
